215319-47-4 Usage
Uses
Used in Pharmaceutical Industry:
Balanophonin, (+)is used as a potential therapeutic agent for neurodegenerative diseases such as Alzheimer's. Its ability to inhibit cholinesterase helps in maintaining higher levels of acetylcholine, which is essential for cognitive function and is often depleted in Alzheimer's patients.
Used in Antioxidant Applications:
Balanophonin, (+)is used as an antioxidant, leveraging its capacity to neutralize harmful free radicals and protect cells from oxidative damage, which is a common factor in many diseases and aging processes.
Used in Anti-inflammatory Applications:
Balanophonin, (+)is used as an anti-inflammatory agent, potentially reducing inflammation which is a key component in various disease conditions and can contribute to neurodegenerative processes.
Further research is necessary to fully understand the pharmacological effects of Balanophonin, (+)and to explore its potential applications in medicine, including its role in the development of new drugs for the treatment of neurodegenerative diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 215319-47-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,5,3,1 and 9 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 215319-47:
(8*2)+(7*1)+(6*5)+(5*3)+(4*1)+(3*9)+(2*4)+(1*7)=114
114 % 10 = 4
So 215319-47-4 is a valid CAS Registry Number.
215319-47-4Relevant academic research and scientific papers
On the absolute structure of optically active neolignans containing a dihydrobenzo[b]furan skeleton
Yuen, Mabel S. M.,Xue, Feng,Mak, Thomas C. W.,Wong, Henry N. C.
, p. 12429 - 12444 (2007/10/03)
Several optically pure neolignans containing a dihydrobenzo[b]furan skeleton were synthesized. Based on an X-ray crystallographic study and circular dichroism results, the absolute configurations of some naturally occurring neolignans, namely balanophonin (1), PGI2 inducer (2), dehydrodiconiferyl alcohol-4-β-D-glucoside (3), dehydroconiferyl alcohol (4) and 3',4-di-O-methylcedrusin (5) have been unambiguously established.